Granulomatous slack skin: Difference between revisions
No edit summary Tag: visualeditor-wikitext |
CSV import |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Granulomatous slack skin | |||
| synonyms = Granulomatous slack skin syndrome | |||
| field = [[Dermatology]] | |||
| symptoms = [[Skin]] laxity, [[granuloma]] formation | |||
| complications = [[Infection]], [[skin cancer]] | |||
| onset = Typically in [[adulthood]] | |||
| duration = Chronic | |||
| causes = Unknown, possibly [[immune system]] related | |||
| risks = [[Genetic predisposition]], [[autoimmune disorders]] | |||
| diagnosis = [[Skin biopsy]], [[histopathology]] | |||
| differential = [[Cutis laxa]], [[elastolysis]], [[lymphoma]] | |||
| treatment = [[Corticosteroids]], [[immunosuppressive therapy]] | |||
| prognosis = Variable, depends on response to treatment | |||
| frequency = Rare | |||
}} | |||
== ''Alternate names''' == | == ''Alternate names''' == | ||
Granulomatous slack skin | Granulomatous slack skin | ||
== '''Definition''' == | == '''Definition''' == | ||
Granulomatous slack skin (GSS) is an extremely rare subtype of [[T-cell cutaneous lymphoma]], characterized by the slow and progressive development of sagging skin of redundant aspect, especially in the flexural areas, such as the [[axillary]] and [[inguinal]] region. | Granulomatous slack skin (GSS) is an extremely rare subtype of [[T-cell cutaneous lymphoma]], characterized by the slow and progressive development of sagging skin of redundant aspect, especially in the flexural areas, such as the [[axillary]] and [[inguinal]] region. | ||
GSS is a very rare cutaneous disorder and less than 50 cases have been reported so far. | GSS is a very rare cutaneous disorder and less than 50 cases have been reported so far. | ||
== '''Cause''' == | == '''Cause''' == | ||
The cause of this condition is unknown but it is often associated with [[mycosis fungiodes]] and other [[lymphoproliferative disorders]] such as [[Hodgkin]] and [[non-Hodgkin lymphoma]]. | The cause of this condition is unknown but it is often associated with [[mycosis fungiodes]] and other [[lymphoproliferative disorders]] such as [[Hodgkin]] and [[non-Hodgkin lymphoma]]. | ||
== '''Signs and symptoms ''' == | == '''Signs and symptoms ''' == | ||
Signs and symptoms include loose hanging skin and fine wrinkling of the skin or [[papules]]. These symptoms are most often located in the axilla, groin and stomach. | Signs and symptoms include loose hanging skin and fine wrinkling of the skin or [[papules]]. These symptoms are most often located in the axilla, groin and stomach. | ||
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. | For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. | ||
30%-79% of people have these symptoms | 30%-79% of people have these symptoms | ||
* [[Erythema]] | * [[Erythema]] | ||
| Line 18: | Line 31: | ||
* Redundant skin(Loose redundant skin) | * Redundant skin(Loose redundant skin) | ||
* Stiff skin | * Stiff skin | ||
5%-29% of people have these symptoms | 5%-29% of people have these symptoms | ||
* Abnormality of the lymph nodes(Abnormal lymph node histology) | * Abnormality of the lymph nodes(Abnormal lymph node histology) | ||
| Line 24: | Line 36: | ||
* [[Hypercalcemia]](High blood calcium levels) | * [[Hypercalcemia]](High blood calcium levels) | ||
* [[Nephrocalcinosis]](Too much calcium deposited in kidneys) | * [[Nephrocalcinosis]](Too much calcium deposited in kidneys) | ||
== '''Diagnosis''' == | == '''Diagnosis''' == | ||
The initial lymph node biopsy suggested [[sarcoidosis]] due to the presence of [[granulomas]]. Only the correlation of the clinical and the histological cutaneous findings allowed the redirection of the diagnosis towards [[T-cell cutaneous lymphoma]]. Clinical followup for a long period of time was also necessary for the final characterization of GSS and its development into high level T-cell cutaneous lymphoma. | The initial lymph node biopsy suggested [[sarcoidosis]] due to the presence of [[granulomas]]. Only the correlation of the clinical and the histological cutaneous findings allowed the redirection of the diagnosis towards [[T-cell cutaneous lymphoma]]. Clinical followup for a long period of time was also necessary for the final characterization of GSS and its development into high level T-cell cutaneous lymphoma. | ||
GMF has been described as the differential diagnosis for GSS. A multicentric recent study conducted by WHO/EORTC concluded that striking clinical differences exist between these two entities, but their histological findings overlap. It is therefore not possible to distinguish them only on histopathological basis. The looseness of the skin in [[flexural areas]] is found only in GSS. The presence of [[elastophagocytosis]] is more characteristic of GSS, however, it can also be observed in GMF. | GMF has been described as the differential diagnosis for GSS. A multicentric recent study conducted by WHO/EORTC concluded that striking clinical differences exist between these two entities, but their histological findings overlap. It is therefore not possible to distinguish them only on histopathological basis. The looseness of the skin in [[flexural areas]] is found only in GSS. The presence of [[elastophagocytosis]] is more characteristic of GSS, however, it can also be observed in GMF. | ||
== '''Treatment''' == | == '''Treatment''' == | ||
There is no specific treatment regimen for GSS. Treatment options are based on the recommendations for [[cutaneous T-cell lymphoma]] and include [[topical steroids]], surgical remvoval of skin folds, [[radiation therapy]] and [[chemotherapy]]. | There is no specific treatment regimen for GSS. Treatment options are based on the recommendations for [[cutaneous T-cell lymphoma]] and include [[topical steroids]], surgical remvoval of skin folds, [[radiation therapy]] and [[chemotherapy]]. | ||
Multiple therapeutic alternatives for GSS have been described, such as topical and systemic [[corticosteroids]], [[PUVA]], [[radiotherapy]], [[multidrug therapy]], [[immunosuppressive agents]] such as [[azathioprine]], [[immunomodulators]] such as [[interferon alpha]], as well as combined therapies. None of these therapies, however, present sustained satisfactory results. The surgical removal of redundant skin with aesthetic and functional purposes tends to relapse. | Multiple therapeutic alternatives for GSS have been described, such as topical and systemic [[corticosteroids]], [[PUVA]], [[radiotherapy]], [[multidrug therapy]], [[immunosuppressive agents]] such as [[azathioprine]], [[immunomodulators]] such as [[interferon alpha]], as well as combined therapies. None of these therapies, however, present sustained satisfactory results. The surgical removal of redundant skin with aesthetic and functional purposes tends to relapse. | ||
The response to isolated PUVA and associated with [[interferon alpha]], [[chemotherapy]] with [[gemcitabine]] and localized [[radiotherapy]] at different times had partial and temporary result. | The response to isolated PUVA and associated with [[interferon alpha]], [[chemotherapy]] with [[gemcitabine]] and localized [[radiotherapy]] at different times had partial and temporary result. | ||
== '''Prognosis''' == | == '''Prognosis''' == | ||
GSS does not entail life-threatening risks, but its prognosis is defined by the development of lympho-proliferative concomitant diseases, such as [[Hodgkin disease]], [[non-Hodgkin lymphoma]], [[fungoides mycosis]], [[acute myelogenous leukemia]] and Langerhans cell [[histiocytosis]], in this order of frequency. This concomitance is very frequent, reaching 50%, according to some authors. | GSS does not entail life-threatening risks, but its prognosis is defined by the development of lympho-proliferative concomitant diseases, such as [[Hodgkin disease]], [[non-Hodgkin lymphoma]], [[fungoides mycosis]], [[acute myelogenous leukemia]] and Langerhans cell [[histiocytosis]], in this order of frequency. This concomitance is very frequent, reaching 50%, according to some authors. | ||
[[Category:Lymphoid-related cutaneous conditions]] | [[Category:Lymphoid-related cutaneous conditions]] | ||
{{Cutaneous-condition-stub}} | {{Cutaneous-condition-stub}} | ||
{{rarediseases}} | {{rarediseases}} | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Latest revision as of 06:04, 4 April 2025
| Granulomatous slack skin | |
|---|---|
| Synonyms | Granulomatous slack skin syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin laxity, granuloma formation |
| Complications | Infection, skin cancer |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly immune system related |
| Risks | Genetic predisposition, autoimmune disorders |
| Diagnosis | Skin biopsy, histopathology |
| Differential diagnosis | Cutis laxa, elastolysis, lymphoma |
| Prevention | N/A |
| Treatment | Corticosteroids, immunosuppressive therapy |
| Medication | N/A |
| Prognosis | Variable, depends on response to treatment |
| Frequency | Rare |
| Deaths | N/A |
Alternate names'[edit]
Granulomatous slack skin
Definition[edit]
Granulomatous slack skin (GSS) is an extremely rare subtype of T-cell cutaneous lymphoma, characterized by the slow and progressive development of sagging skin of redundant aspect, especially in the flexural areas, such as the axillary and inguinal region. GSS is a very rare cutaneous disorder and less than 50 cases have been reported so far.
Cause[edit]
The cause of this condition is unknown but it is often associated with mycosis fungiodes and other lymphoproliferative disorders such as Hodgkin and non-Hodgkin lymphoma.
Signs and symptoms [edit]
Signs and symptoms include loose hanging skin and fine wrinkling of the skin or papules. These symptoms are most often located in the axilla, groin and stomach. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 30%-79% of people have these symptoms
- Erythema
- Hodgkin lymphoma
- Redundant skin(Loose redundant skin)
- Stiff skin
5%-29% of people have these symptoms
- Abnormality of the lymph nodes(Abnormal lymph node histology)
- Acute kidney injury
- Hypercalcemia(High blood calcium levels)
- Nephrocalcinosis(Too much calcium deposited in kidneys)
Diagnosis[edit]
The initial lymph node biopsy suggested sarcoidosis due to the presence of granulomas. Only the correlation of the clinical and the histological cutaneous findings allowed the redirection of the diagnosis towards T-cell cutaneous lymphoma. Clinical followup for a long period of time was also necessary for the final characterization of GSS and its development into high level T-cell cutaneous lymphoma. GMF has been described as the differential diagnosis for GSS. A multicentric recent study conducted by WHO/EORTC concluded that striking clinical differences exist between these two entities, but their histological findings overlap. It is therefore not possible to distinguish them only on histopathological basis. The looseness of the skin in flexural areas is found only in GSS. The presence of elastophagocytosis is more characteristic of GSS, however, it can also be observed in GMF.
Treatment[edit]
There is no specific treatment regimen for GSS. Treatment options are based on the recommendations for cutaneous T-cell lymphoma and include topical steroids, surgical remvoval of skin folds, radiation therapy and chemotherapy. Multiple therapeutic alternatives for GSS have been described, such as topical and systemic corticosteroids, PUVA, radiotherapy, multidrug therapy, immunosuppressive agents such as azathioprine, immunomodulators such as interferon alpha, as well as combined therapies. None of these therapies, however, present sustained satisfactory results. The surgical removal of redundant skin with aesthetic and functional purposes tends to relapse. The response to isolated PUVA and associated with interferon alpha, chemotherapy with gemcitabine and localized radiotherapy at different times had partial and temporary result.
Prognosis[edit]
GSS does not entail life-threatening risks, but its prognosis is defined by the development of lympho-proliferative concomitant diseases, such as Hodgkin disease, non-Hodgkin lymphoma, fungoides mycosis, acute myelogenous leukemia and Langerhans cell histiocytosis, in this order of frequency. This concomitance is very frequent, reaching 50%, according to some authors.
NIH genetic and rare disease info[edit]
Granulomatous slack skin is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Granulomatous slack skin
|


